2020
October 2020
It is our pleasure to announce that ODP’s 2020 Early-Stage Investigator Lecture awardee is Dr. Julia Marcus. Her research focuses on improving the implementation of pre-exposure prophylaxis (PrEP) for HIV prevention. We spoke to Dr. Marcus to learn more about her work, her perspective on the challenges facing HIV prevention research, and her approach to public health.
August 2020
After several years of work and collaboration, the ODP is excited to share the Federal Partners Meeting Report for the Pathways to Prevention Workshop on Achieving Health Equity in Preventive Services. The report highlights opportunities for collaboration and resources that researchers and government agencies can use to address disparities in the use of clinical services for early detection and prevention of common chronic conditions such as cancer, heart disease, and diabetes.
July 2020
The coronavirus pandemic continues to impact the way we live, learn, and engage with one another. Even as our communities begin to reopen, taking preventive measures—such as wearing a mask to cover your nose and mouth, physical distancing, and frequently washing your hands—is still critically important to help reduce the spread of this virus. Unfortunately, these measures often make in-person learning much less feasible.
May 2020
The coronavirus disease 2019 (COVID-19) pandemic has changed all our lives in so many ways, and it has certainly changed things for the ODP. Like many of you, we have moved to full-time telework as a means of physical distancing to help reduce the spread of COVID-19. It is critically important for all of us to take these kinds of preventive measures, and we all have a role to play in protecting each other’s health.
January 2020
We are excited to share our Spotlight on 2019 report highlighting a few of the ODP's accomplishments last year. The report summarizes key projects related to each of the ODP’s six strategic priorities and outlines how they impact public health.
2019
November 2019
A new paper from the Office of Disease Prevention (ODP) reports that the level of support from the National Institutes of Health (NIH) for prevention research on the leading risk factors and causes of death and disability in the United States falls well below their burden on the nation's health.
September 2019
On August 15 the U.S. Food and Drug Administration issued a proposed new rule to require color graphic health warnings for cigarette packaging and advertisements. Helen Meissner, Ph.D., Sc.M. discusses the research behind the proposed new graphic health warnings for cigarette packaging and advertisements.
May 2019
On March 27, 2019, Drs. Valerie Earnshaw and Siobhan Phillips came to the NIH to present their work. We sat down with them for a conversation about how they arrived in their areas of research and what advice they have for graduate students and fellows looking to follow similar paths.
February 2019
Physical activity is one of the best ways to improve health, no matter your age; however, evidence shows that Americans aren’t getting enough of it. According to federal monitoring data, only 26% of men, 19% of women, and 20% of adolescents meet the guidelines for physical activity.
2018
November 2018
This is a guest message from Sheri D. Schully, Ph.D. Dr. Schully leads the ODP team that analyzes and monitors NIH investments in prevention research, including developing new methods and tools for characterizing NIH research. In October 2018, Dr. Schully and her team published two papers in the American Journal of Preventive Medicine about the ODP’s analysis of the NIH prevention research portfolio.
October 2018
I am pleased to present the ODP Strategic Plan for Fiscal Years 2019–2023, Prevention Research: Building a Healthier Future. This plan outlines how our efforts will help shape the landscape of prevention research over the next 5 years and presents the priorities for the Office.
May 2018
The All of Us Research Program, which began national enrollment on May 6, is a historic effort to gather data from 1 million or more people living in the United States to advance individualized prevention, treatment, and care for people of all backgrounds. Supported by the National Institutes of Health (NIH), All of Us is expected to be the largest and most diverse longitudinal health research program ever developed.
2017
October 2017
Strategic Priority IV aims to promote collaboration in prevention research across the NIH and with government and private partners. The goal is to identify and share best practices and models in collaboration, build support infrastructure, and coordinate funding opportunities.
July 2017
The goal of Strategic Priority III is to promote the best available methods in prevention research. Over the past year, the ODP has continued to work toward improving the quality of prevention research methods by updating and expanding its prevention science tools and training opportunities.
May 2017
Identifying research gaps can lead to new research that ultimately improves the public health. With Strategic Priority II, the ODP identifies prevention research areas for investment or further expansion by the NIH.
March 2017
The Office of Disease Prevention’s (ODP) Strategic Priority I focuses on the development of new tools to characterize the National Institutes of Health (NIH) prevention research portfolio.
2016
December 2016
The mid-course of the ODP Strategic Plan for Fiscal Years 2014–2018 offers the opportunity to highlight accomplishments for the six priority areas in 2016 and provide an update on the Tobacco Regulatory Science Program (TRSP).
October 2016
The ODP is leveraging its website and other digital communication tools to increase the visibility of and foster work on prevention research at the NIH and across the country.
August 2016
The ODP has collaborated with multiple partners to fund research and training opportunities, initiate first steps in a trans-NIH dissemination and implementation (D&I) portfolio analysis, and provide information and tools to support investigators, public health professionals, and other stakeholders.
June 2016
On May 5, 2016, the FDA issued its final deeming rule to extend its authorities to all categories of products that meet the statutory definition of "tobacco product" in the Federal Food, Drug, and Cosmetic Act, except accessories of such newly deemed tobacco products.
April 2016
Strategic Priority IV aims to encourage collaboration among NIH Institutes and Centers (ICs) and their government and private partners engaged in prevention research to identify and share best collaborative practices and models, build support infrastructure, and coordinate funding opportunities.
February 2016
To enhance the quality of prevention research at the NIH, the ODP is working to promote the use of the best available methods in prevention research and support the development of prevention science tools.
January 2016
As the ODP enters the third year of its Strategic Plan, progress has been made with the six strategic priorities and the Tobacco Regulatory Science Program (TRSP).
2015
October 2015
Despite overall progress in reducing tobacco consumption, tobacco remains the leading cause of preventable disease and death in the United States. There is growing concern about the potential public health impact of new tobacco products, such as electronic cigarettes (e-cigarettes)—particularly among youth.
August 2015
Identifying research gaps can lead to increased efforts and new research that ultimately improve public health. To achieve this aim, the Office of Disease Prevention (ODP) is identifying prevention research areas for investment or expanded effort by the NIH.
June 2015
Preventable health risks, such as smoking, obesity, and physical inactivity, cause up to half of all deaths in the United States. To reduce these risks and the associated burden of disease, the NIH spends approximately 20% of its annual budget on prevention research.
2014
August 2014
As we enter the new fiscal year, I am pleased to report on the progress we have made related to the Office of Disease Prevention's (ODP) first Strategic Plan. This plan, which was approved by the NIH Director in January 2014, includes six strategic priorities that will guide the work of our office through 2018.
February 2014
As we enter 2014, I am pleased to announce the completion of the Office of Disease Prevention's (ODP) first strategic plan. After a year of hard work, this plan was approved by the National Institutes of Health (NIH) Director on January 2, 2014. We identified six strategic priorities, highlighted below, that will guide the work of the Office during 2014-2018:
2013
August 2013
When I came to the Office of Disease Prevention (ODP) in October 2012, I was excited at the prospect of leading a new strategic planning effort, developing new programs, strengthening partnerships within the National Institutes of Health (NIH) and with other federal agencies, and expanding our dissemination efforts. I am pleased to report our progress to date, with much more to come in the future.
